Vous êtes ici : Accueil > Laboratoire BCI > Publications du laboratoire en 2012

Publications du laboratoire en 2012

Publié le 30 janvier 2019

Araujo-Jorge TC, Waghabi MC, Bailly S and Feige JJ
The TGF-beta pathway as an emerging target for Chagas disease therapy.
Clinical Pharmacology & Therapeutics, 2012, 92(5): 613-621

Bidart M, Ricard N, Levet S, Samson M, Mallet C, David L, Subileau M, Tillet E, Feige JJ and Bailly S
BMP9 is produced by hepatocytes and circulates mainly in an active mature form complexed to its prodomain.
Cellular and Molecular Life Sciences, 2012, 69(2): 313-324
Erratum in: Cell Mol Life Sci, 2012, 69(3):485

Brouillet S, Hoffmann P, Chauvet S, Salomon A, Chamboredon S, Sergent F, Benharouga M, Feige JJ and Alfaidy N
Revisiting the role of hCG: New regulation of the angiogenic factor EG-VEGF and of its receptors.
Cellular and Molecular Life Sciences, 2012, 69(9): 1537-1550

Brouillet S, Hoffmann P, Feige JJ and Alfaidy N
EG-VEGF: A key endocrine factor in placental development.
Trends in Endocrinology and Metabolism, 2012, 23(10): 501–508

Chervin-Petinot A, Courcon M, Almagro S, Nicolas A, Grichine A, Grunwald D, Prandini MH, Huber P and Gulino-Debrac D
Epithelial protein lost in neoplasm (EPLIN) interacts with α-catenin and actin filaments in endothelial cells and in vitro stabilizes the vascular capillary network.
Journal of Biological Chemistry, 2012, 287(10): 7556-7572

Ciais D and Bailly S
BMPs go for apelin to regulate angiogenesis. Focus on "Inhibition of apelin expression by BMP signaling in endothelial cells".
American Journal of Physiology-Cell Physiology, 2012, 303(11): C1127-1128

de Bentzmann S, Giraud C, Bernard CS, Calderon V, Ewald F, Plesiat P, Nguyen C, Grunwald D, Attree I, Jeannot K, Fauvarque MO and Bordi C
Unique biofilm signature, drug susceptibility and decreased virulence in Drosophila through the Pseudomonas aeruginosa two-component system PprAB.
PLoS Pathogens, 2012, 8(11): e1003052

Deroux A, Baudet A, Chiquet C, Altayrac J, Gallice M, Romanet JP, Gulino D, Vilgrain I and Bouillet L
Caractérisation d’anticorps anti-VE-cadhérine dans la choriorétinopathie de Birdshot.
La Revue de Médecine Interne, 2012, 33, Supplement 2(0): A67

Dupuis-Girod S, Ginon I, Saurin JC, Marion D, Guillot E, Decullier E, Roux A, Carette MF, Gilbert-Dussardier B, Hatron PY, Lacombe P, Lorcerie B, Rivière S, Corre R, Giraud S, Bailly S, Paintaud G, Ternant D, Valette PJ, Plauchu H and Faure F
Bevacizumab in patients with hereditary hemorrhagic telangiectasia and severe hepatic vascular malformations and high cardiac output.
Journal of the American Medical Association, 2012, 307(9): 948-955

Filhol O, Ciais D, Lajaunie C, Charbonnier P, Foveau N, Vert JP and Vandenbrouck Y
DSIR: Assessing the design of highly potent siRNA by testing a set of cancer-relevant target genes.
PLoS One, 2012, 7(10): e48057

Forsman H, Andréasson E, Karlsson J, Boulay F, Rabiet MJ and Dahlgren C
Structural characterization and inhibitory profile of formyl peptide receptor 2 selective peptides descending from a PIP2-binding domain of gelsolin.
Journal of Immunology, 2012, 189(2): 629-637

Gendrin C, Contreras-Martel C, Bouillot S, Elsen S, Lemaire D, Skoufias DA, Huber P, Attree I and Dessen A
Structural basis of cytotoxicity mediated by the Type III Secretion Toxin ExoU from Pseudomonas aeruginosa
PLoS Pathogens, 2012, 8(4): e1002637

Herbet M, Salomon A, Feige JJ and Thomas M
Acquisition order of Ras and p53 gene alterations defines dictinct adrenocortical tumor phenotypes.
PLoS Genetics, 2012, 8(5): e1002700

Hoffmann P, Brouillet S, Benharouga M, Feige JJ and Alfaidy N
Role of EG-VEGF in human placentation: Physiological and pathological implications In Recent Advances In Research on The Human Placent, édité par Zheng J, InTech, 2012, Chap 14, pp 287-306

Liu F, Kang I, Park C, Chang LW, Wang W, Lee D, Lim DS, Vittet D, Nerbonne JM and Choi K
ER71 specifies Flk-1+ hemangiogenic mesoderm by inhibiting cardiac mesoderm and Wnt signaling.
Blood, 2012, 119(14): 3295-3305

Motta FN, Bastos IM, Faudry E, Ebel C, Lima MM, Neves D, Ragno M, Barbosa JA, de Freitas SM and Santana JM
The Trypanosoma cruzi virulence factor oligopeptidase B (OPBTc) assembles into an active and stable dimer.
PLoS One, 2012, 7(1): e30431

de Oliveira FL, Araujo-Jorge TC, de Souza EM, de Oliveira GM, Degrave WM, Feige JJ, Bailly S and Waghabi MC
Oral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in chagas disease.
PLoS Neglected Tropical Diseases, 2012, 6(6): e1696

Philibert C, Bouillot S, Huber P and Faury G
Protocadherin-12 deficiency leads to modifications in the structure and function of arteries in mice.
Pathologie Biologie, 2012, 60(1): 34–40

Prudent R, Vassal-Stermann E, Nguyen CH, Pillet C, Martinez A, Prunier C, Barette C, Soleilhac E, Filhol O, Beghin A, Valdameri G, Honore S, Aci-Seche S, Grierson D, Antonipillai J, Li R, Di Pietro A, Dumontet C, Braguer D, Florent JC, Knapp S, Bernard O and Lafanechere L
Pharmacological inhibition of LIM kinase stabilizes microtubules and inhibits neoplastic growth.
Cancer Research, 2012, 72(17): 4429-4439

Ricard N, Ciais D, Levet S, Subileau M, Mallet C, Zimmers TA, Lee SJ, Bidart M, Feige JJ and Bailly S
BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
Blood, 2012, 119(25): 6162-6171

Sidibe A, Mannic T, Arboleas M, Subileau M, Gulino-Debrac D, Bouillet L, Jan M, Vandhuick T, Le Loet X, Vittecoq O and Vilgrain I
Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: Evidence for tumor necrosis factor alpha-induced VE-cadherin cleavage.
Arthritis and Rheumatism, 2012, 64(1): 77-87

Singh P, Soon PS, Feige JJ, Chabre O, Zhao JT, Cherradi N, Lalli E and Sidhu SB
Dysregulation of microRNAs in adrenocortical tumors.
Molecular and Cellular Endocrinology, 2012, 351(1): 118-128

Tahtouh T, Elkins JM, Filippakopoulos P, Soundararajan M, Burgy G, Durieu E, Cochet C, Schmid RS, Lo DC, Delhommel F, Oberholzer AE, Pearl LH, Carreaux F, Bazureau JP, Knapp S and Meijer L
Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B.
Journal of Medicinal Chemistry, 2012, 55(21): 9312-9330

Vérove J, Bernarde C, Bohn YS, Boulay F, Rabiet MJ, Attrée I and Cretin F
Injection of Pseudomonas aeruginosa Exo toxins into host cells can be modulated by host factors at the level of translocon assembly and/or activity.
PLoS One, 2012, 7(1): e30488

Vittet D, Merdzhanova G, Prandini MH, Feige JJ and Bailly S
TGFss1 inhibits lymphatic endothelial cell differentiation from mouse embryonic stem cells.
Journal of Cellular Physiology, 2012, 227(11): 3593-3602